Dr. Osarogiagbon on Geographic Disparities in Lung Cancer

Video

Raymond U. Osarogiagbon, MD, FACP, discusses geographic disparities in lung cancer.

Raymond U. Osarogiagbon, MD, FACP, chief scientist, Baptist Memorial Health Care, director, Multidisciplinary Thoracic Oncology Program, Thoracic Oncology Research Group, Baptist Cancer Center, discusses geographic disparities in lung cancer.

Lung cancer is a public health challenge worldwide, but the patterns of incidence and mortality are not geographically uniform, Osarogiagbon says. For example, the incidence and mortality rates associated with lung cancer vary from country to country, Osarogiagbon adds. For example, in the United States, the 5 states with the highest rates of lung cancer and lung-cancer related mortality include Kentucky, Mississippi, Arkansas, West Virginia, and Tennessee, Osarogiagbon explains. Moreover, this correlates with the same states that have high rates of tobacco use, Osarogiagbon continues. It is known that smoking remains the most significant risk factor for lung cancer, which makes it important to note the cultural acceptances of tobacco use, Osarogiagbon explains.

The tobacco belt of the United States is also the ​"cancer mortality belt​" of the United States, which identifies one type of geographic disparity, Osarogiagbon concludes.

Related Videos
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine
Naomi Adjei, MD, MPH, MSEd, gynecologic oncology fellow, The University of Texas MD Anderson Cancer Center
John M. Kirkwood, MD, Distinguished Service Professor of Medicine, Sandra and Thomas Usher Professor of Medicine, Dermatology & Translational Science, coleader, Melanoma and Skin Cancer Program, Division of Hematology/Oncology, the University of Pittsburgh
Nizar M. Tannir, MD, FACP, professor; Ransom Horne, Jr. Professor for Cancer Research, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
William B. Pearse, MD
Daniel Olson, MD
Nan Chen, MD
Robert Dreicer, MD, director, Solid Tumor Oncology, Division of Hematology/Oncology, professor of Medicine and Urology, deputy director, University of Virginia Cancer Center
Akriti Jain, MD
Samer A. Srour, MB ChB, MS